Malignancies in Korean Patients with Inflammatory Myopathy
0
조회
0
다운로드
6
인용
0
참고문헌
초록
The aim of this study was to assess the prevalence and the common type of malignancies in Korean patients with polymyositis (PM) and dermatomyositis (DM) and to evaluate the differences of clinical and laboratory findings between patients with malignancy and those without malignancy. Forty-one Korean patients, who were diagnosed as PM or DM, were enrolled in this study. They fulfilled the Bohan and Peter's criteria for a definite diagnosis of PM and DM. Patients with PM were 25 and those with DM were 16. Eleven out of 41 patients (26.8%) had malignancies. The malignancy was diagnosed simultaneously or later in 81.8% of patients with inflammatory myopathy (IM). The breast cancer was the most common malignancy. In this study, forty three years old as a screening age for malignancy had 88.9% sensitivity and 50.2% specificity. The serum levels of creatine kinase (CK) were significantly lower in patients with malignancy than those without malignancy.
Abstract
The aim of this study was to assess the prevalence and the common type of malignancies in Korean patients with polymyositis (PM) and dermatomyositis (DM) and to evaluate the differences of clinical and laboratory findings between patients with malignancy and those without malignancy. Forty-one Korean patients, who were diagnosed as PM or DM, were enrolled in this study. They fulfilled the Bohan and Peter's criteria for a definite diagnosis of PM and DM. Patients with PM were 25 and those with DM were 16. Eleven out of 41 patients (26.8%) had malignancies. The malignancy was diagnosed simultaneously or later in 81.8% of patients with inflammatory myopathy (IM). The breast cancer was the most common malignancy. In this study, forty three years old as a screening age for malignancy had 88.9% sensitivity and 50.2% specificity. The serum levels of creatine kinase (CK) were significantly lower in patients with malignancy than those without malignancy.
참고문헌 (13)
- "Rheumatic syndromes associated with malignancy", 15, pp.35~43 (2003)
- "Incidence of malignant disease in biopsy-proven inflammatory myopathy", 134, pp.1087~1095 (2001)
- "Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria", 28, pp.723~741 (2002)
- "Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study", 41, pp.729~734 (2002)
- "Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study", 144, pp.825~831 (2001)
- "Dermatomyositis and cancer: East and West", 42, pp.699~700 (2000)
- "A clinical analysis of 39 patients with dermatomyositis-polymyositis", pp.104~11
- "A clinical analysis of 100 patients with dermatomyositis-polymyositis", pp.812~22
- "Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study", 357, pp.96~100 (2001)
- "Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases", 48(uira r), pp.530~534 (2003)
- "Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark", 6, pp.9~13 (1995)
- "Annual report of the Korea central cancer registry program 2000: based on registered data from 131 hospitals", 34, pp.77~83 (2002)
- "Polymyositis-dermatomyositis and malignant lesions: does an association exist?", pp.645~53